Dr Trube Cassandra Miller, PHD | |
5118 Holly Way, Abilene, TX 79606-5969 | |
(903) 818-5979 | |
Not Available |
Full Name | Dr Trube Cassandra Miller |
---|---|
Gender | Female |
Speciality | Behavior Analyst |
Location | 5118 Holly Way, Abilene, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285065052 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 64745 (Texas) | Secondary |
103K00000X | Behavior Analyst | 1-17-26192 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Trube Cassandra Miller, PHD 5118 Holly Way, Abilene, TX 79606-5969 Ph: (903) 818-5979 | Dr Trube Cassandra Miller, PHD 5118 Holly Way, Abilene, TX 79606-5969 Ph: (903) 818-5979 |
News Archive
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today the initiation of two clinical trials with OSI-906, the Company's potential first-in-class, oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor. The first study is a Phase III, multi-center study that will evaluate the use of OSI-906 for patients with locally advanced or metastatic adrenocortical carcinoma (ACC).
Twenty young and promising researchers from Nijmegen - eleven from Radboud University and nine from Radboudumc - are each to receive up to 250,000. NWO (The Netherlands Organisation for Scientific Research) is awarding the Veni grant as part of the Innovational Research Incentives Scheme.
Covered California, the state's health insurance marketplace under the Affordable Care Act, has devised what could be a powerful new way to hold hospitals accountable for the quality of their care. Starting in less than two years, if the hospitals haven't met targets for safety and quality, they'll risk being excluded from the "in-network" designation of health plans sold on the state's insurance exchange.
A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic.
› Verified 1 days ago